Simpson Thacher Represents BioClinica, Inc. in Financing in Connection with its Announced Merger with CCBR-SYNARC, Inc.
01.24.14
This is only gets display when printing
The Firm is representing BioClinica, Inc., which is jointly controlled by JLL Partners and Ampersand Capital Partners, in connection with the financing of its merger with CCBR-SYNARC Inc., a Water Street Healthcare Partners portfolio company. BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. CCBR-SYNARC Inc. provides clinical services to the world's largest pharmaceutical and biotechnology companies, specializing in imaging services, consultation and analysis to track progress throughout a clinical trial's life cycle. The combined company will become the market-leading provider of four highly specialized services that increase the speed and efficiency of global clinical trials.
The transaction is expected to close in the first quarter of 2014.
The Simpson Thacher team includes Chris Brown and Andy Veit (Banking and Credit).